Cargando…
A blood-brain barrier-penetrating AAV2 mutant created by a brain microvasculature endothelial cell-targeted AAV2 variant
Upon systemic administration, adeno-associated virus serotype 9 (AAV9) and the capsid variant PHP.eB show distinct tropism for the central nervous system (CNS), whereas AAV2 and the capsid variant BR1 transduce brain microvascular endothelial cells (BMVECs) with little transcytosis. Here, we show th...
Autores principales: | Kawabata, Hayato, Konno, Ayumu, Matsuzaki, Yasunori, Hirai, Hirokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036519/ https://www.ncbi.nlm.nih.gov/pubmed/36970652 http://dx.doi.org/10.1016/j.omtm.2023.02.016 |
Ejemplares similares
-
Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model
por: Huda, Fathul, et al.
Publicado: (2014) -
GABAergic neuron-specific whole-brain transduction by AAV-PHP.B incorporated with a new GAD65 promoter
por: Hoshino, Chiaki, et al.
Publicado: (2021) -
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning
por: Nonnenmacher, Mathieu, et al.
Publicado: (2020) -
Viral Vector-Based Dissection of Marmoset GFAP Promoter in Mouse and Marmoset Brains
por: Shinohara, Yoichiro, et al.
Publicado: (2016) -
Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain
por: Stone, Daniel, et al.
Publicado: (2023)